One example is the immunostaining of EGFR1 (epidermal growth factor receptor-1) and HER-2 (human epidermal growth factor receptor 2), which are considered potential predictors of tumor response to lapatinib (Anjos et al., 2024). The gene discussed is ERBB2; the disease is neoplasm.